Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $85 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity and venture capital. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact

Sign on to your account

Media Contacts

Featured Article

Real Estate // December 15, 2017

Bain Capital Establishes Real Estate Business

BOSTON, December 15, 2017 – Bain Capital, one of the world’s leading private, multi-asset alternative investment firms, today announced the formation of Bain Capital Real Estate, comprised of the professionals currently managing Harvard Management Company’s (HMC) real estate investments. Effective February 1, 2018, the HMC Real Estate Team, which consists of approximately 20 dedicated...

  • 12.23.17
    Private Equity

    Bain Capital Private Equity acquires Fedrigoni

    LONDON, MILAN, December 23, 2017 – Bain Capital Private Equity, a leading global private investment firm, announced that it has signed a definitive agreement to acquire Fedrigoni, a leading global producer of specialty papers and self-adhesive labels. The Fedrigoni family will retain a minority stake in the business.Established in 1888 and headquartered in Verona, Italy, Fedrigoni is...

  • 12.21.17

    Bain Capital Credit Acquires a Portfolio of 103 Repossessed Assets in Italy

    LONDON, December 21, 2017 – Bain Capital Credit, LP, (“Bain Capital Credit”) and Castello SGR S.p.A. (“Castello”), announced today that they have agreed to acquire a portfolio of 103 residential, industrial and commercial real estate assets, named Project Hemera, from Intesa Sanpaolo S.p.A. (“Intesa”).The portfolio comprises assets repossessed from terminated leasing or loan...

  • 12.18.17
    Life Sciences

    Aptinyx Raises $70 Million in Series B Financing to Advance Growing Pipeline through Clinical Studies in Neurologic Disorders

    EVANSTON, ILLINOIS, December 18, 2017 – Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today is announcing the completion of a $70 million Series B financing to fund advancement of its expanding clinical-stage pipeline. The financing was led by Bain Capital Life Sciences. Additional new investors include Adage...

  • 12.18.17
    Private Equity

    Bain Capital Private Equity-led consortium acquires Trans Maldivian Airways

    HONG KONG, December 18, 2017 – Bain Capital Private Equity ("Bain Capital") today announced that it has formed a consortium to acquire Trans Maldivian Airways ("TMA"), the world’s largest seaplane operator headquartered in the Maldives, from a private equity firm. The Bain Capital-led consortium includes Shenzhen Tempus Global Business Services Holdings Ltd ("Tempus Global") (300178) and TBRJ...

  • 12.12.17
    Private Equity

    Toshiba and Western Digital Reach Global Settlement and Agree to Strengthen Flash Memory Collaboration

    TOKYO, December 13, 2017 and SAN JOSE, CALIFORNIA December 12, 2017 – Toshiba Corporation (TOKYO: 6502) (“Toshiba”), Toshiba Memory Corporation (“TMC”) and Western Digital Corporation (NASDAQ: WDC) (“Western Digital”) have entered into a global settlement agreement to resolve their ongoing disputes in litigation and arbitration, strengthen and extend their relationship, and enhance...

  • 12.7.17
    Private Equity

    Bain Capital Private Equity and ASATSU-DK announce successful tender offer

    TOKYO, December 7, 2017 – Bain Capital Private Equity and ASATSU-DK are pleased to announce that Bain Capital has successfully acquired an 87.05% stake in ASATSU-DK (ADK, 9747:TSE) through a tender offer. As announced on October 2, 2017, Bain Capital launched the tender offer to acquire the common shares of ADK with a view to privatizing the business and delisting it from the Tokyo Stock...

  • 12.1.17

    Antares and Bain Capital Credit Form Unitranche Joint Venture

    CHICAGO and BOSTON, December 1, 2017 — Antares Capital LP (“Antares”) and Bain Capital Credit (“Bain Capital”), today announced the formation of a joint venture providing a unified, private lender solution to private equity backed middle market borrowers.  The joint venture, which will be marketed as the Antares Bain Capital Complete Financing Solution (“ABCS”), provides private...

  • 11.10.17
    Private Equity

    Axis Bank Board Approves a Capital Raise of Rs. 11,626 Crores

    MUMBAI, November 10, 2017 - Axis Bank, the third largest private sector bank in India, today announced that it proposes to raise equity and equity-linked capital of Rs. 11,626 Crores from a set of marquee investors including entities affiliated with Bain Capital Private Equity and the Bank’s Promoter Life Insurance Corporation of India.  Entities affiliated with Bain Capital propose to invest...

  • 10.23.17

    Bain Capital Credit Agrees to Establish a Joint Venture to Manage Real Estate Assets Portfolio from Liberbank

    LONDON, October 23, 2017 – Bain Capital Credit, LP announced today that it has entered into a binding agreement to establish a joint venture company, which will own and manage a portfolio of repossessed real estate assets from Liberbank. Bain Capital will control and manage the JV with an 80% stake with the two other shareholders being Liberbank and Oceanwood. Bain Capital Credit now owns and...

  • 10.13.17
    Life Sciences

    InflaRx announces a $55M Series D financing and investment round to foster its clinical stage complement anti-C5a development programs

    JENA, GERMANY, October 13, 2017 - InflaRx, the biopharmaceutical company developing new therapeutics in the terminal complement space, announced today a $ 55M Series D financing and investment round. The round was co-led by Bain Capital Life Sciences LP, Cormorant Asset Management LLC and RA Capital Management LLC and complemented by certain investment funds managed by a leading US investment...

Latest @BainCapital tweets